semaglutide vomiting after eating Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Semaglutide side effects for diabetes

Plans are offered as a subscription service which can be canceled at any time

Biopsy-proven NASH : Patients with histologically confirmed NASH, particularly those with significant inflammation or early fibrosis (F1-F2), may be considered for off-label GLP-1 therapy, especially if they have failed lifestyle modification or have contraindications to other therapies like vitamin E or pioglitazone

Endothelial overexpression of metallothionein prevents diabetes-induced impairment in ischemia angiogenesis through preservation of HIF-1 alpha/SDF-1/VEGF signaling in endothelial progenitor cells

protect against kidney damage during peritoneal dialysis (Kihm 2011)

In the UK, the Food Foundation reported in May 2026 that nearly 7% of the population had already used GLP-1 drugs, while a further 8% had considered or were considering them